STING Pathway Targeting Therapeutics and Technologies, 2020-2030 by Roots Analysis
To order this detailed 310+ page report, please visit this - https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
Key Inclusions
§
A detailed assessment
of the current market landscape of therapeutics targeting STING pathway, based
on several parameters, such as type of STING modulator (agonist or antagonist),
type of molecule (small molecules, cyclic dinucleotides, non-nucleotides,
biologics and others), phase of development (discovery, preclinical and
clinical), target therapeutic area(s), type of therapy (monotherapy and
combination therapy), route of administration (intratumoral, intravenous and others),
and line of treatment (last line, second line or greater and first line or
greater). The chapter also features an analysis of the developer landscape
(including information on year of establishment, company size, geography and
most active players). Further the chapter includes an analysis on the clinical
trials focused on STING, along with information on parameters, such as
recruitment status, study design and clinical endpoints.
§
A detailed chapter
highlighting various technology platforms that are being actively used for the
development of STING modulators and analysis based on several parameters, such
as type of modulator (agonist or antagonist), type of molecule (small
molecules, cyclic dinucleotides, non-nucleotides, live biotherapeutics,
nanoparticles and synthetic peptides), and analysis based on technology
developer landscape (including information on year of establishment, company
size and geography).
§
Elaborate profiles of
key players that are engaged in the development of therapeutics targeting STING
pathway (shortlisted on the basis of phase of development of pipeline
products), featuring a brief overview of the company, its financial information
(if available), detailed descriptions of their respective lead drug candidates,
recent developments and an informed future outlook. Additionally, each drug
profile features information on the type of drug, route of administration,
target indications and current status of development.
§
Tabulated profiles of
industry players (shortlisted on the basis of the antagonist in pipeline
products), featuring details on the innovator company (such as year of
establishment, location of headquarters, number of employees, key members of
the executive team and recent developments), along with descriptions of their
respective drug candidates.
§
A study on various
grants that have been awarded to research institutes engaged in projects
related to STING pathway, during the period 2015 - Q1 2020, based on multiple
parameters, such as number of grants awarded, amount awarded, funding
institute, support period, funding mechanism, type of grant application, grant
activity code, most popular NIH department, type of recipient organization,
regional distribution, most popular recipient organization(s), prominent
project leader(s) and study section. It also includes an analysis of on grant
attractiveness.
§
An analysis of big
pharma players engaged in the development of therapeutics targeting STING
pathway, based on several parameters, such as portfolio diversity, type of
molecule, phase of development, therapeutic area(s), type of therapy and route
of administration. In addition, the chapter features a benchmarking analysis of
the aforementioned players.
§
An analysis of the
start-ups / small players (established in the last ten years, less than 50
employees) engaged in the development of therapeutics targeting STING pathway,
based on several relevant parameters, such as portfolio diversity, type of
molecule, phase of development, therapeutic area, funding received, number of
investors, type of funding, partnership activity, number of patents filed,
grants received, and start-up health indexing.
§
A detailed
publication analysis of more than 300 peer-reviewed, scientific articles that
have been published during the period 2019 - Q1 2020, highlighting the research
focus within the industry. It also highlights the key trends observed across
publications, including information on type of publication, year of
publication, study objective, popular keywords, type of STING modulator, target
pathway, therapeutic area, type of publisher, leading players (in terms of
number of publications), region, first author organization and key journals (in
terms of number of articles published in this domain).
§
An analysis of the
partnerships that have been established in the domain, over the period 2015 -
Q1 2020, covering research agreements, product / technology licensing
agreements, mergers / acquisitions,
R&D and commercialization agreements, IP licensing agreements,
clinical trial agreements, product development agreements, and other relevant
deals. The chapter highlights analysis based on year of partnerships, type of
partnership model, type of STING modulator, therapeutic area, technology
platform, most active player(s) (in terms of number of partnerships inked), and
region.
§
An analysis of the
investments made at various stages of development, such as seed financing,
venture capital financing, debt financing, grants / awards, capital raised from
IPOs and subsequent offerings, by companies engaged in this field. The chapter
highlights analysis based on the number of funding instances, amount invested,
type of funding, type of STING modulator, therapeutic area, technology
platform, most active player(s) (in terms of number of funding instances), most
active investor(s) (in terms of number of funding instances) and geographical
region.
The report also features the likely
distribution of the current and forecasted opportunity across important market
segments, mentioned below:
§
Types of Payment
§
Upfront Payments
§
Milestone Payments
§
Type of STING Modulator
§
Agonist
§
Antagonist
§
Key Therapeutic Area(s)
§
Oncological Disorders
§
Inflammatory Disorders
§
Infectious Diseases
§
Others
§
Route of Administration
§
Intratumoral
§
Intravenous
§
Oral
§
Subcutaneous
§
Others
§
Type of Molecule
§
Non-nucleotide
§
Cyclic Dinucleotide
§
Live Biotherapeutics
§
Oncolytic Peptides
§
Synthetic Peptides
§
Others
§
Key Geographical Regions
§
North America
§
Europe
§
Asia-Pacific
To request sample pages, please visit this -
https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
Key
Questions Answered
§ Who are
the leading developers of STING pathway targeting therapeutics and affiliated
technologies?
§ What are
the most popular STING pathway related technology platforms in the market?
§ What are
the key therapeutic areas for which STING pathway targeting therapeutics are
being / have been developed?
§ What kind
of partnership models are commonly adopted by stakeholders engaged in this
industry?
§ What is
the trend of capital investment for STING pathway targeting therapeutics and
technologies?
§
How is the current and future opportunity likely to be
distributed across key market segments in this domain?
You may also be interested in the following titles:
1. Nuclear Medicine and
Radiopharmaceuticals Manufacturing Market, 2020-2030
2. Global
Psychedelic Therapeutics Market by Type of Psychedelic
Substance (Ketamine, Psilocybin, MDMA and Others), by Origin (Natural and
Synthetic), by Type of Therapy (Monotherapy, Combination and Others), by Route
of Administration (Oral, Intravenous, Intranasal and Others) and by Key
Geographies (North America, Europe and Asia- Pacific and rest of the world):
Industry Trends and Global Forecasts, 2020-2030
3.
Endocannabinoid
System Targeted Therapeutics Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Comments
Post a Comment